Key facts
- This page summarizes John Drayton Wise's Form 4 filing for INSMED Inc (INSM).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 07 Feb 2025, 17:11.
John Drayton Wise - 05 Feb 2025 Form 4 Insider Report for INSMED Inc (INSM)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- INSM
- Reported as of
- 05 Feb 2025
- Net transaction value
- -$640,708
- SEC form
- 4
- Accepted by SEC
- 07 Feb 2025, 17:11:09 UTC
- Prior SEC filing
- 10 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Drayton Wise, by Michael A. Smith as Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John Drayton Wise filed Form 4 for INSMED Inc (INSM) on 07 Feb 2025.
Change
- Previous filing in this sequence was filed on 10 Jan 2025.
- Current net transaction value: -$640,708.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INSM
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +15,373
- Change %
- +12%
- Price
- $0.000000
- Shares after
- 140,935
- Date
- 05 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
INSM
transaction
Common Stock
Sale
- Transaction value
- $639,919
- Shares
- -7,910
- Change %
- -5.6%
- Price
- $80.90
- Shares after
- 133,025
- Date
- 06 Feb 2025
- Ownership
- Direct
- Footnotes
- F2, F3
INSM
transaction
Common Stock
Sale
- Transaction value
- $789
- Shares
- -10
- Change %
- -0.01%
- Price
- $78.91
- Shares after
- 133,015
- Date
- 07 Feb 2025
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions.
Footnote F2
Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees.
Footnote F3
This is the weighted average sales price representing 7,910 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.